Interaction of small molecule inhibitors of HIV-1 entry with CCR5-Reference-Cited by-同舟云学术

Interaction of small molecule inhibitors of HIV-1 entry with CCR5

Published:2006-05 Issue:1 Volume:349 Page:41-54
ISSN:0042-6822
Container-title:Virology
language:en
Short-container-title:Virology

Author:

Seibert Christoph,Ying Weiwen,Gavrilov Svetlana,Tsamis Fotini,Kuhmann Shawn E.,Palani Anandan,Tagat Jayaram R.,Clader John W.,McCombie Stuart W.,Baroudy Bahige M.,Smith Steven O.,Dragic Tatjana,Moore John P.,Sakmar Thomas P.

Publisher

Elsevier BV

Subject

Virology

Reference80 articles.

1. A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity;Baba;Proc. Natl. Acad. Sci. U.S.A.,1999

2. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease;Berger;Annu. Rev. Immunol.,1999

3. A single amino acid explains the differential sensitivity of human and rhesus macaque CCR5 to small molecule inhibitors of human immunodeficiency virus type 1 entry and suggests a mechanism of action for these inhibitors;Billick;J. Virol.,2004

4. Multiple charged and aromatic residues in CCR5 amino-terminal domain are involved in high affinity binding of both chemokines and HIV-1 Env protein;Blanpain;J. Biol. Chem.,1999

5. The core domain of chemokines binds CCR5 extracellular domains while their amino terminus interacts with the transmembrane helix bundle;Blanpain;J. Biol. Chem.,2003

Cited by 111 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current status of the small molecule anti-HIV drugs in the pipeline or recently approved;Bioorganic & Medicinal Chemistry;2024-09

2. Bioorthogonal Tethering Enhances Drug Fragment Affinity for G Protein-Coupled Receptors in Live Cells;Journal of the American Chemical Society;2023-04-28

3. The rise of deep learning and transformations in bioactivity prediction power of molecular modeling tools;Chemical Biology & Drug Design;2021-09-16

4. Chemokine receptor CCR5 correlates with functional CD8 + T cells in SIV‐infected macaques and the potential effects of maraviroc on T‐cell activation;The FASEB Journal;2019-04-29

5. Clonal analysis of HIV-1 genotype and function associated with virologic failure in treatment-experienced persons receiving maraviroc: Results from the MOTIVATE phase 3 randomized, placebo-controlled trials;PLOS ONE;2018-12-26